Vaccines containing per-glycosylated MUC1 antigens, when injected in PBS without external adjuvant or formulation into liposomes, induced high titers of MUC1 antibodies capable of recognizing MCF-7 breast cancer cells. This evidence concerns the gene MUC1 and breast carcinoma.